高脂血症
脂肪性肝炎
生物
纤维化
脂肪变性
脂肪肝
非酒精性脂肪性肝炎
癌症研究
生物信息学
细胞生物学
内科学
内分泌学
医学
非酒精性脂肪肝
疾病
糖尿病
作者
Taihu Wu,Xi Chen,Kequan Xu,Caixia Dai,Xiaomian Li,Yang-Wen-Qing Zhang,Jinghua Li,Meng Gao,Yingyi Liu,Fusheng Liu,Xutao Zhang,Bi‐Cheng Wang,Peng Xia,Zhen Li,Weijie Ma,Yufeng Yuan
出处
期刊:Hepatology
[Wiley]
日期:2023-09-01
卷期号:79 (1): 149-166
被引量:2
标识
DOI:10.1097/hep.0000000000000585
摘要
Hyperlipidemia has been extensively recognized as a high-risk factor for NASH; however, clinical susceptibility to NASH is highly heterogeneous. The key controller(s) of NASH susceptibility in patients with hyperlipidemia has not yet been elucidated. Here, we aimed to reveal the key regulators of NASH in patients with hyperlipidemia and to explore its role and underlying mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI